Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Cripto-1 expression increases the expression of TNF-alpha in CD4+ T cells in tissues affected by chronic inflammatory disease. More
Neomics has found a very promising target, AIMP2/AIMP2-DX2 for siRNA therapy application to tumoric lung cancer cells and we intend to focus the remaining resources on developing through clinical trials, the siRNA therapy as a first priority More
A simple blood based assay to identify diabetic patients who are likely to develop or have early stage diabetic nephropathy has been developed at King's. This has the potential to be used regularly at diabetic clinics. More
Therapeutic method to treat prostate carcinomas by administration of cellular PAcP protein. More
Recently characterized MUC17 gene highly specific for pancreatic cancer. More
Acetaminophen-protein Adduct Dipstick: rapid, sensitive and specific diagnostic device for point-of-care determination of acetaminophen toxicity More
Diagnostic and potential therapeutic applications for mucin gene 4 (MUC4). More
Monoclonal antibody for a novel HIV protein with potential diagnostic, prognostic, and therapeutic uses. More
Cripto-1 is overexpressed in infarcted myocardial tissue More
A microRNA gene expression profile in prostate cancers that correlates with androgen responsiveness More
Related Reports
Market Research Reports provided by reports.innovaro.com
May 2011 - 102 pages - $3,835
Apr 2011 - 951 pages - $4,995
Aug 2008 - 352 pages - $2,615
Nov 2011 - 50 pages - $3,800
The Convergence of Biomarkers and Diagnostics: Therapy area analyses, key products and future trends
Apr 2008 - 265 pages - $3,835
Jan 2007 - 90 pages - $1,995
Aug 2010 - 27 pages - $125
Sep 2010 - 25 pages - $99
Jun 2011 - 187 pages - $3,835
Feb 2012 - 1350 pages - $2,695
Your selection
Browse By
- Therapeutic target
- Accident and Trauma
- Allergy
- Blood and forming organs
- Cardiovascular
- Central Nervous System
- Dermatological
- Endocrinology
- Gastrointestinal
- Genetic disorders
- Genito-urinary
- Hospital and Surgery
- Immune related disorders
- Infectious diseases
- Metabolism
- Musculoskeletal
- Oncology
- Oral Health
- Other therapeutic
- Respiratory
- Sensory organ
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2012 Innovaro Europe Ltd 
All rights reserved. Terms and Conditions | Contact us